Deutsche Bank Downgrades HEALTHSOUTH (HLS) to Hold

Deutsche Bank downgraded HEALTHSOUTH (NYSE: HLS) from Buy to Hold with a price target of $25.00 (from $28.50).

The firm comments, "HLS is an extremely well-managed company with a strong business model, excellent balance sheet; it maintains nice flexibility to return more capital to shareholders due to its FCF profile. HLS' revenue growth prospects remain underpinned by good organic volume trends, acceleration of de novos and JV/M&A opportunities. Despite our favorable view for "HLS the company," we see a more balanced risk/reward for "HLS the stock," with the potential for Medicare pressure over the next 12-24 months the key gaiting factor for HLS' valuation multiple."

For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.

Shares of HEALTHSOUTH closed at $23.86 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Evercore ISI Downgrades SunPower (SPWR) to In Line
• Southern Co. (SO) PT Raised to $73 at BofA Securities
• Kinross Gold (K:CN) (KGC) PT Raised to Cdn$12.50 at Canaccord Genuity